New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)

New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)

Bibliographic Details
Main Authors:	Fairclough, R, Guiraud, S, Squire, SE, Babbs, A, Edward, B, Shah, N, Bracchi, A, Wilson, F, Horne, G, Robinson, N, Araujo, N, Hewings, D, Vuorinen, A, Davies, S, Wynne, G, Russell, A, Tinsley, J, Davies, K
Format:	Conference item
Published:	2014

Similar Items

Utrophin in the therapy of Duchenne Muscular Dystrophy
by: Potter, A, et al.
Published: (2006)

Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD)
by: Tinsley, J, et al.
Published: (2013)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2012)

Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
by: Fairclough, R, et al.
Published: (2008)

Second-generation compound for the modulation of utrophin in the therapy of DMD
by: Guiraud, S, et al.
Published: (2015)

Analysis of the transcriptional control of utrophin promoters as a therapeutic strategy for Duchenne muscular dystrophy (DMD).
by: Perkins, K, et al.
Published: (2000)

Utrophin upregulation in Duchenne muscular dystrophy.
by: Hirst, R, et al.
Published: (2005)

Identification of serum protein biomarkers for utrophin based DMD therapy.
by: Guiraud, S, et al.
Published: (2017)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2002)

Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
by: Guiraud, S, et al.
Published: (2018)

Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
by: Chancellor, DR, et al.
Published: (2011)

From diagnosis to therapy in Duchenne muscular dystrophy
by: Babbs, A, et al.
Published: (2020)

Utrophin upregulation in DMD therapy: current status and new tools for the future
by: Fairclough, R, et al.
Published: (2011)

Regenerative biomarkers for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
by: Griffin, J, et al.
Published: (2002)

Progress in therapy for Duchenne muscular dystrophy.
by: Fairclough, R, et al.
Published: (2011)

Progress in therapy for Duchenne muscular dystrophy
by: Fairclough, R, et al.
Published: (2011)

Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in Duchenne and Becker muscular dystrophy muscle biopsies
by: Janghra, N, et al.
Published: (2016)

Pharmacological advances for treatment in Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2017)

Regenerative biomarkers for Duchenne muscular dystrophy
by: Simon Guiraud, et al.
Published: (2019-01-01)

Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model
by: Babbs, A, et al.
Published: (2019)

Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy
by: Sewry, C, et al.
Published: (2004)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
by: Perkins, K, et al.
Published: (2018)

Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
by: Rodger Sunil, et al.
Published: (2012-11-01)

Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research
by: Bareja, A
Published: (2011)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2015)

Promising therapeutic approaches of utrophin replacing dystrophin in the treatment of Duchenne muscular dystrophy
by: Ruo Wu, et al.
Published: (2022-11-01)

Mechanism of action studies of the utrophin modulator ezutromid for the treatment of Duchenne muscular dystrophy
by: Wilkinson, I
Published: (2019)

Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
by: Catherine Moorwood, et al.
Published: (2011-01-01)

Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
by: Davies, K, et al.
Published: (2019)

Utrophin in therapy of Duchenne muscular distrophy
by: Fisher, R
Published: (2001)

Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients.
by: Marianna Laviola, et al.
Published: (2018-01-01)

Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy.
by: Fairclough, R, et al.
Published: (2012)

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
by: Fairclough, R, et al.
Published: (2013)

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
by: Perkins, K, et al.
Published: (2001)

Identification of Two Novel Variants of the DMD Gene in Chinese Families with Duchenne Muscular Dystrophy
by: Wu J, et al.
Published: (2023-08-01)

A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20
by: Sara Mata López, et al.
Published: (2018-05-01)

Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
by: Michael Gapinske, et al.
Published: (2023-09-01)

AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy
by: Goyenvalle, A, et al.
Published: (2010)